Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02041325 · BASELINE

Baseline characteristics

Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias · Source last updated 2016-05-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      22
    2. group Id
      BG001
      value
      16
    3. group Id
      BG002
      value
      38
    units
    Participants
groups
  1. description
    Subjects will receive oral CC-5013 (lenalidomide) at 25 mg qd for 7 days prior to and 7 days after the vaccine.
    id
    BG000
    title
    Lenalidomide
  2. description
    Subjects will receive placebo for 7 days prior to and 7 days after the vaccine.
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          46
          upper Limit
          90
          value
          77
        2. group Id
          BG001
          lower Limit
          47
          upper Limit
          78
          value
          67.5
        3. group Id
          BG002
          lower Limit
          46
          upper Limit
          90
          value
          72.3
    dispersion Type
    FULL_RANGE
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          5
        2. group Id
          BG001
          value
          6
        3. group Id
          BG002
          value
          11
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          17
        2. group Id
          BG001
          value
          10
        3. group Id
          BG002
          value
          27
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          22
        2. group Id
          BG001
          value
          16
        3. group Id
          BG002
          value
          38
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      22
    2. group Id
      BG001
      value
      16
    3. group Id
      BG002
      value
      38
    units
    Participants
groups
  1. description
    Subjects will receive oral CC-5013 (lenalidomide) at 25 mg qd for 7 days prior to and 7 days after the vaccine.
    id
    BG000
    title
    Lenalidomide
  2. description
    Subjects will receive placebo for 7 days prior to and 7 days after the vaccine.
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          46
          upper Limit
          90
          value
          77
        2. group Id
          BG001
          lower Limit
          47
          upper Limit
          78
          value
          67.5
        3. group Id
          BG002
          lower Limit
          46
          upper Limit
          90
          value
          72.3
    dispersion Type
    FULL_RANGE
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          5
        2. group Id
          BG001
          value
          6
        3. group Id
          BG002
          value
          11
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          17
        2. group Id
          BG001
          value
          10
        3. group Id
          BG002
          value
          27
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          22
        2. group Id
          BG001
          value
          16
        3. group Id
          BG002
          value
          38
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice